Goldman Sachs’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$541K Sell
7,600
-132,400
-95% -$10.4M ﹤0.01% 5554
2025
Q4
$11.5M Hold
140,000
﹤0.01% 2962
2025
Q3
$10.5M Hold
140,000
﹤0.01% 2911
2025
Q2
$10.4M Hold
140,000
﹤0.01% 2724
2025
Q1
$11.3M Buy
140,000
+90,000
+180% +$7.73M ﹤0.01% 2579
2024
Q4
$3.91M Hold
50,000
﹤0.01% 3699
2024
Q3
$4.69M Buy
+50,000
New +$4.2M ﹤0.01% 3395
2023
Q2
Sell
-18,975
Closed -$1.56M 5864
2023
Q1
$1.56M Buy
+18,975
New +$1.35M ﹤0.01% 4048

Other funds holding GEHC

Goldman Sachs's GEHC Position: Q1 2026 in Review

Goldman Sachs reduced its GE HealthCare (GEHC) stake by 3.3% in Q1 2026, selling an estimated $8.92M and leaving 3,266,138 shares worth $232M. The position accounts for 0.03% of the portfolio, ranked #611.

Goldman Sachs first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $277M in Q4 2025. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Goldman Sachs held 3,266,138 shares of GE HealthCare worth $232M as of Q1 2026.
  • Goldman Sachs sold 113,086 GE HealthCare shares in Q1 2026, an estimated $8.92M.
  • GE HealthCare made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #611 holding.
  • Goldman Sachs first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Goldman Sachs's GE HealthCare position peaked at $277M in Q4 2025.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.